Dihydroergotamine and Reteplase, recombinant Intravenous
Determining the interaction of Dihydroergotamine and Reteplase, recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection)
Generic Name: reteplase
Brand name: Retavase, Retavase Half-Kit
Synonyms: Reteplase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine-Retin A
- Dihydroergotamine-Retin-A (Tretinoin Cream)
- Dihydroergotamine-Retin-A (Tretinoin Gel)
- Dihydroergotamine-Retin-A Cream, Gel, Liquid
- Dihydroergotamine-Retin-A Micro
- Dihydroergotamine-Retin-A Micro Topical
- Reteplase, recombinant Intravenous-Dihydroergotamine injection
- Reteplase, recombinant Intravenous-Dihydroergotamine Mesylate
- Reteplase, recombinant Intravenous-Dihydroergotamine nasal
- Reteplase, recombinant Intravenous-Dihydroergotamine Nasal Spray
- Reteplase, recombinant Intravenous-Dilacor XR
- Reteplase, recombinant Intravenous-Dilantin